Research Topics
Genomes and GenesSpecies | W R SperrSummaryAffiliation: University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of diseaseWolfgang R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Int Arch Allergy Immunol 128:136-41. 2002..The serum tryptase level is used as a diagnostic marker in mastocytosis and is considered to reflect the burden of (neoplastic) mast cells (MC)...
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systemsW R Sperr
Department of Internal Medicine I, University of Vienna, Austria
Ann Hematol 80:272-7. 2001..Karyotype-based multiparameter systems appear to be particularly effective in defining MDS patients who are at high risk of transforming to leukemia...
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Blood 98:2200-9. 2001..Blast cell persistence or regrowth was associated with a persistently elevated level or recurrent increase of tryptase. Together, tryptase is expressed in myeloblasts in a group of AML and may serve as a useful disease-related marker...
Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosisWolfgang R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Int Arch Allergy Immunol 127:140-2. 2002..No general guidelines for the treatment of patients with SM-AHNMD have been established so far. A reasonable straightforward approach may be to treat the AHNMD in those patients in the same way as if no coexisting SM exists...
Tryptase a novel biochemical marker of acute myeloid leukemiaWolfgang R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Leuk Lymphoma 43:2257-61. 2002..We hypothesize that tryptase-positive AMLs arise from a leukemic progenitor that exhibits a limited potential to differentiate into mast cells and/or basophils...
Clinical and biologic diversity of leukemias occurring in patients with mastocytosisW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Leuk Lymphoma 37:473-86. 2000..In the present article, the concomitant occurrence of mastocytosis and leukemia is discussed in the light of the literature and of concepts proposed to explain the biologic basis of this phenomenon...
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodiesW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Int Arch Allergy Immunol 122:279-86. 2000..Whether such autoantibodies are recurrently produced in patients with Schnitzler's syndrome and play a role in the pathophysiology of the disease remains to be determined...
Treatment concepts for elderly patients with acute myeloid leukemiaWolfgang R Sperr
Division of Hematology and Hemostaseology, Department of Internal Medicine I, University of Vienna, Vienna, Austria
Wien Klin Wochenschr 115:505-14. 2003..The therapeutic efficiency and toxicity-profiles of these novel drugs are currently under investigation in clinical trials...
Human leukaemic stem cells: a novel target of therapyW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Eur J Clin Invest 34:31-40. 2004..The present article gives an overview of our knowledge about AML stem cells, their phenotype, and their role as a 'therapy-target' in new concepts to treat and to cure patients with AML...
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr
Leuk Lymphoma 43:1097-105. 2002..In addition, serum tryptase levels appear to correlate with MDS variants. Follow up studies should clarify whether an elevated tryptase concentration in MDS is of prognostic significance...
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5)Wolfgang R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Institute of Medical Biology, and Institute of Medical and Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Clin Cancer Res 10:3965-71. 2004..High-dose intermittent cytarabine is an effective postremission treatment for patients with acute myeloid leukemia (AML). This regimen is a safe approach in patients < 60 years but produced severe neurotoxicity in the elderly...
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisisP Valent
Department of Internal Medicine, University of Vienna, Austria
Blood 84:4322-32. 1994....
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent
Department of Internal Medicine I, Division of Hematology, University of Vienna, Währinger Gürtel 18 20 Vienna, Austria
Leuk Res 25:603-25. 2001..Criteria proposed in this article should be helpful in this regard...
Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cellsW R Sperr
Department of Internal Medicine I, University of Vienna, Austria
Int Arch Allergy Immunol 102:170-5. 1993..Furthermore, MCs could be desensitized specifically by pre-incubation of MCs with rhSCF in Ca-free medium. Together, these data suggest that SCF triggers mediator secretion from MCs in various organs via binding to the c-kit receptor...
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cellH Agis
Department of Internal Medicine I, University of Vienna, Austria
J Immunol 151:4221-7. 1993..This is the first definitive demonstration that mast cells are replenished directly from early hemopoietic progenitors and thus form a unique cell lineage within the hemopoietic system...
Variable expression of activation-linked surface antigens on human mast cells in health and diseaseP Valent
Department of Internal Medicine I, University of Vienna, Austria
Immunol Rev 179:74-81. 2001..The present article gives an overview of MC phenotypes in health and disease, and attempts to provide explanations for the phenotypic variability of MC...
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosisW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, , 1090 Vienna, Austria
Leuk Res 25:529-36. 2001..These data suggest that cytomorphological assessment of bm MC in SM is an important diagnostic approach that may help to delineate between variants of the disease...
Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cellsM T Krauth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Allergy 61:281-8. 2006..The other statins tested (simvastatin, pravastatin) did not affect mediator release or growth of MCs. CONCLUSIONS: Cerivastatin and atorvastatin act as inhibitors of growth and function of human MCs...
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosisP Valent
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Leuk Res 25:595-602. 2001..Whether these neoplasms display aberrant gene expression (or gene defects) or represent 'pre-pre-mast cell leukemias', remains unknown...
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromesW Füreder
Department of Internal Medicine I, Division of Hematology and Hemostaseology, The University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Eur J Clin Invest 31:894-901. 2001..However, little is known so far about basophil granulocytes in MDS...
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kitM Willheim
Institute of General and Experimental Pathology, University of Vienna, Neubau AKH, Austria
J Immunol Methods 182:115-29. 1995..Thus, by combining isolation techniques including elutriation, magnetic cell depletion and cell sorting with mAb, functionally intact normal human basophils and mast cells can be enriched to homogeneity...
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollenS Vrtala
Institute of General and Experimental Pathology, Vienna General Hospital, University of Vienna, Austria
J Immunol 163:5489-96. 1999....
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-ValJ H Jordan
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Leuk Res 25:627-34. 2001..Because of the 'intermediate' clinical signs and absence of progression to aggressive disease, we proposed the term 'smouldering mastocytosis'...
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccinationM Focke
Department of Pathophysiology, Vienna General Hospital, AKH, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
FASEB J 15:2042-4. 2001..We thus demonstrate that synthetic hypoallergenic peptides derived from B cell epitopes of major allergens represent safe vaccine candidates for the treatment of IgE- mediated allergies...
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromesF Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, , A-1090, Vienna, Austria
Leuk Res 25:287-94. 2001..The LDH activity should be considered as an important prognostic factor in MDS...
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L)J H Jordan
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Hum Pathol 32:545-52. 2001..Apart from these, CD2 may be a novel useful marker because MCs in mastocytosis frequently express this antigen, whereas MCs in other pathologic conditions are CD2 negative...
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cellsA W Hauswirth
Department of Medicine I, Medical University of Vienna, Austria
Eur J Clin Invest 37:73-82. 2007..In the present study, we asked whether leukaemic stem cells in patients with AML express CD33...
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasmsP Samorapoompichit
Institute of Histology and Embryology, Department of Internal Medicine I, University of Vienna, Vienna, Austria
Blood 98:2580-3. 2001..Therefore, tryptase should not be regarded as specific for mast cells when neoplastic myeloid cells are analyzed...
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccinationM Focke
Department of Pathophysiology, Vienna General Hospital, Medical University of Vienna, Austria
Clin Exp Allergy 34:1525-33. 2004..Almost 100 million allergic patients are sensitized to the major birch pollen allergen, Bet v 1, a 17 kDa protein containing most of the IgE epitopes present in pollens of trees belonging to the Fagales order and plant-derived food...
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571)H Agis
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Center of Excellence for Clinical and Experimental Oncology CLEXO, Medical University of Vienna, Austria
Ann Oncol 18:1834-41. 2007..Therefore, monitoring of minimal residual disease (MRD) during treatment with imatinib is important. However, most MRD-parameters are expensive and require special technology. We determined the value of histamine as MRD-marker in CML...
Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromesF Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Ann Oncol 19:970-6. 2008..In a screen program searching for dynamic prognostic determinants, we have identified lactate dehydrogenase (LDH) as a most suitable follow-up parameter...
Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergyA W Hauswirth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Int J Immunopathol Pharmacol 20:267-78. 2007..Compared to FcepsilonRI-mediated cell activation, IL-3-induced upregulation of CD203c is a late(r) event and is not accompanied by upregulation of CD63...
Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progressionF Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Eur J Clin Invest 38:447-55. 2008..Basophilic crisis and eosinophilia are well recognized features of advanced chronic myeloid leukaemia. In other myeloid neoplasms, however, transformation with marked basophilia and eosinophilia is considered unusual...
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupW R Sperr
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, A 1090 Vienna, Austria
Ann Oncol 21:114-9. 2010..The evaluation of comorbidity is of increasing importance in patients with hematologic disorders...
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosisK J Aichberger
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Eur J Clin Invest 38:869-73. 2008..Cladribine (2CdA) and dasatinib are two drugs that counteract the in vitro growth of neoplastic mast cells in SM. However, only little is known about the in vivo effects of these drugs in SM...
Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligandH C Bankl
Department of Internal Medicine I, University of Vienna, Austria
Circulation 91:275-83. 1995..The role of redistributed MC and their mediators in the pathophysiology of atrial thrombosis requires further investigation...
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linkingA W Hauswirth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Int J Immunopathol Pharmacol 21:797-806. 2008..In conclusion, CD203c is a novel activation-linked surface antigen on MC that is upregulated in response to IgE receptor cross-linking and is overexpressed on neoplastic MC in patients with SM...
Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitorsG-H Schernthaner
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Allergy 60:1248-55. 2005..Whereas IL-3R and GM-CSFRs are lost during differentiation of MC, these cells may acquire complement receptors (CD35, CD88) under the influence of distinct cytokines...
Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbuminA Bugajska-Schretter
Institute of Medical and Chemical Laboratory Diagnostics, AKH, University of Vienna, Austria
Gut 46:661-9. 2000..Almost 4% of the population suffer from food allergy which is an adverse reaction to food with an underlying immunological mechanism...
Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsA Bohm
Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 39:395-405. 2009..Three mTOR-targeting drugs, rapamycin, everolimus (RAD001) and CCI-779, were applied. The effects of these drugs on growth, survival, apoptosis and VEGF expression in primary AML cells and various AML cell lines were examined...
Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopyP Samorapoompichit
Centre of Anatomy and Cell Biology, Institute of Histology and Embryology, Medical University of Vienna, , A-1090 Vienna, Austria
Histopathology 48:247-57. 2006..CONCLUSION: Immunoelectron microscopy may be a helpful approach in confirming the identity of neoplastic MC in myeloid neoplasms...
Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disordersJ-H Jordan
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, , A-1090 Vienna, Austria
Eur J Clin Invest 33:611-8. 2003..An elevated CFU level in SM should raise the suspicion of an associated MPD (CMML) or smouldering SM, a novel SM-subtype that shares several features with MPD and sometimes progresses to an overt SM-MPD...
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromesJ Loeffler-Ragg
Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria
Crit Rev Oncol Hematol 78:150-61. 2011..037) and in the IPSS intermediate-1-risk group (p=0.015). The CD44s-adjusted IPSS defines a cohort of MDS patients with unfavorable prognosis, which might be helpful in risk stratification and in therapeutic algorithms...
Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniquesF Wimazal
Department of Internal Medicine I, University of Vienna, Austria
Tissue Antigens 54:499-507. 1999..In summary, Ba and MC express a unique profile of homing molecules. Apparently, Ba differ from MC in expression of recognition receptors relevant for binding to endothelium and consecutive transmigration...
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment conceptsP Valent
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
Eur J Clin Invest 34:41-52. 2004..The therapeutic potential of target-specific approaches in malignant mast cell disorders should be evaluated in forthcoming clinical trials in the near future...
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematologyW R Sperr
Medical University of Vienna, A 1090 Vienna, Austria
Eur J Clin Invest 39:914-23. 2009..Recent data suggest that tryptase, a mast cell enzyme, is expressed in neoplastic cells in myeloid leukaemias. In several of these patients, increased serum tryptase levels are detectable...
Deferasirox induces regression of iron overload in patients with myelodysplastic syndromesF Wimazal
Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 39:406-11. 2009..A major disadvantage of deferoxamine is that the drug has to be applied as continuous subcutaneous infusion. Therefore, novel oral agents have been developed. One of these drugs is deferasirox (Exjade)...
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapseA Weltermann
Department of Internal Medicine I, Division of Haematology and Haemostasis, Vienna University Hospital, Vienna, Austria
Leukemia 18:293-302. 2004..In conclusion, our results indicate that both karyotype and the duration of first CR are independent prognostic factors for patients with de novo AML in first relapse...
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cellsP Valent
Department of Internal Medicine I, The University of Vienna, Austria
Thromb Haemost 87:786-90. 2002..Whether an altered availability of components of this cellular repair system can predispose for thrombophilia remains to be determined...
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromesA Berer
Department of Internal Medicine I, Division of Hematology, University of Vienna, , 1090, Vienna, Austria
Ann Hematol 82:271-7. 2003..018) to predict survival in our patients. After inclusion of the IPSS risk categories, mCFU levels remained a highly predictive parameter for survival ( p=0.0056) and acute myeloblastic leukemia (AML) transformation ( p=0.0003)...
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteriaP Valent
Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 37:435-53. 2007..Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials...
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemiaC Sillaber
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 38:43-52. 2008..Recent data suggest that the mammalian target of rapamycin (mTOR) is involved in the regulation of growth of neoplastic cells in chronic myeloid leukaemia (CML)...
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgES Laffer
Department of Pathophysiology, AKH, University of Vienna, Vienna, Austria
J Allergy Clin Immunol 108:409-16. 2001..CONCLUSION: Fab12 represents a candidate molecule for therapy of atopy and asthma because it can be used for the depletion of circulating IgE antibodies, as well as for the depletion of IgE-bearing cells...
Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemiaS Preuner
Children s Cancer Research Institute, Vienna, Austria
Eur J Cancer 48:233-6. 2012..Recent data indicate that detection of BCR/ABL1 mutant subclones does not permit prediction of their expansion dynamics and their potential to become drivers of resistant disease...
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromesT Nösslinger
Third Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
Ann Oncol 21:120-5. 2010..The aim of this analysis was to study age and gender as interacting variables for individualized prognostication...
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann
Ludwig Boltzmann Cluster Oncology, Vienna, Austria
Curr Cancer Drug Targets 12:51-63. 2012..Together, our data suggest that Hsp32 plays an important role as a survival factor in leukemic stem cells and as a potential new target in AML...
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergenM Binder
Division of Specific Prophylaxis and Tropical Medicine and Immunopathology, Department of Pathophysiology, University of Vienna, Vienna, Austria
J Immunol 167:5470-7. 2001..Recombinant arginine kinase may be used to identify a group of polysensitized indoor allergic patients and for immunotherapy of these individuals...
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapyK J Aichberger
Medical University of Vienna, Austria
Eur J Clin Invest 37:808-13. 2007..The BCR/ABL tyrosine kinase inhibitor imatinib is highly effective in patients with CML, but hardly crosses the blood-brain barrier...
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodiesN Mothes
Department of Pathophysiology, Vienna General Hospital, University of Vienna, Vienna, Austria
Clin Exp Allergy 33:1198-208. 2003..These blocking antibodies may have protective effects by inhibiting immediate-type reactions and systemic increases of IgE responses caused by seasonal allergen exposure...
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantationA Boehm
Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Austria
Eur J Clin Invest 38:945-52. 2008..Recent data suggest that, among other factors, comorbidity may be an important prognostic variable in patients with myelodysplastic syndromes (MDS) who are eligible for haematopoietic stem cell transplantation (SCT)...
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosisR Fritsche-Polanz
Department of Laboratory Medicine, Division of Endocrinology and Metabolism, University of Vienna, Vienna, Austria
Br J Haematol 113:357-64. 2001..The C-KIT 1642A-->C polymorphism is not associated with myelodysplastic syndrome or systemic mastocytosis...
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platformP Valent
Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Austria
Eur J Clin Invest 38:143-9. 2008..These recommendations should facilitate and assist in recognition of iron overload, selection of patients, timing of treatment, drug selection and the measurement of treatment responses...
Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosusW Füreder
Department of Internal Medicine I, University of Vienna, Austria
Lupus 11:221-6. 2002..01), but thrombopoietin levels were not significantly different. Taken together, thrombopoietin levels are significantly higher in the sera of SLE patients than in healthy controls and anti-thrombopoietin antibodies are frequently found...
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cellsW Füreder
Department of Internal Medicine, University of Vienna, Austria
J Immunol 155:3152-60. 1995....
A patient with de novo AML M1 and t(16;21) with karyotype evolutionAndrea Zatkova
Leuk Res 31:1319-21. 2007
Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndromeKaroline Sonneck
Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
Int Arch Allergy Immunol 142:158-64. 2007..Patients with mastocytosis may suffer from severe hypotension after wasp or bee stings. In these patients, no specific IgE is detectable, but they usually have skin lesions and an elevated serum tryptase level...
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugsPuchit Samorapoompichit
Institute of Histology and Embryology, The University of Vienna, Vienna, Austria
Leuk Lymphoma 44:509-15. 2003..Whether these drugs, alone or in combination, are also effective in patients with MCL, remains to be determined...
Neoplastic stem cells: a novel therapeutic target in clinical oncologyAxel Schulenburg
Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
Cancer 107:2512-20. 2006....
Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816VFriedrich Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Leuk Lymphoma 45:723-9. 2004..In summary, our data show that the spleen can be a primary site of disease in rare cases of SM. Mastocytosis should therefore be considered as a (rare) differential diagnosis in patients with splenomegaly of unknown etiology...
Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemiaKaroline Sonneck
Department of Internal Medicine I, Division of Hematology and Hemostaseology - the Center of Excellence for Clinical and Experimental Oncology (CLEXO, Medical University of Vienna, Austria
Leuk Lymphoma 47:897-906. 2006..Together, tryptase is secreted from AML blasts as a biologically active molecule that may exhibit paracrine rather than autocrine effects in AML...
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB categoryMinoo Ghannadan
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Am J Clin Pathol 119:663-71. 2003..In summary, VEGF expression in the bone marrow is restricted to certain stages of differentiation and maturation of myeloid cells and correlates with the FAB category...
Diagnosis and treatment of systemic mastocytosis: state of the artPeter Valent
Department of Internal Medicine I, Division of Haematology, University of Vienna, Austria
Br J Haematol 122:695-717. 2003
Immunological characterization and antibacterial function of persisting granulocytes in leukemic patients receiving pulse cytosine arabinoside-consolidation chemotherapy on days 1, 3, and 5Maria-T Krauth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Center of Excellence in Clinical and Experimental Oncology, Vienna, Austria
J Immunol 176:1759-68. 2006..IDAC is a superior protocol in this regard and may therefore be most suitable for elderly patients and those at high risk for severe infections...
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Leuk Res 31:727-36. 2007..Respective algorithms and recommendations should facilitate diagnostic and prognostic evaluations in MDS, selection of patients for therapies, and the conduct of clinical trials...
Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interfaceFriedrich Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Leuk Res 31:1461-8. 2007..The phrase "idiopathic cytopenia of undetermined significance (ICUS)", as also suggested by Mufti and co-workers, is proposed and long term follow-up is recommended to assess the evolution...
Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3Yasamin Majlesi
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, , A-1090 Vienna, Austria
J Leukoc Biol 73:107-17. 2003..Together, these data identify cerivastatin and atorvastatin as novel inhibitors of growth and activation of human basophils...
Increased angiogenesis in the bone marrow of patients with systemic mastocytosisFriedrich Wimazal
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Am J Pathol 160:1639-45. 2002..The notion that SM is associated with increased BM angiogenesis and vascular endothelial growth factor expression may have implications for the biology of disease and development of new treatment strategies...
Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteriaJohn-Hendrik Jordan
Department of Internal Medicine 1, University of Vienna, , Austria
Leuk Lymphoma 43:575-82. 2002..Based on our case and similar cases mimicking mastocytosis, it seems of importance to apply recently established SM criteria in order to discriminate between reactive MC hyperplasia and true mastocytosis with certainty...
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathyAlexander W Hauswirth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
Leuk Res 26:601-6. 2002..These data show that some patients with SM can remain in a clinically indolent smouldering state over years even when presenting with marked eosinophilia and lymphadenopathy...
Detection of novel CD antigens on the surface of human mast cells and basophilsMinoo Ghannadan
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, , A-1090 Vienna, Austria
Int Arch Allergy Immunol 127:299-307. 2002..The use of novel CD antibodies may help to isolate MC and basophils and to study their functional properties...
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cellsPeter Valent
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Hematol J 3:90-4. 2002..In the few patients recorded so far, a complex karyotype without recurring anomaly was found. The prognosis appears to be grave, although complete remission in response to chemotherapy has been described...
Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative diseaseAlexander W Hauswirth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria
Hum Pathol 39:917-24. 2008..The KIT mutation D816V was detected in sorted CD34(+) cells and unfractionated marrow cells but not in CD5(+) SLL cells, confirming the coexistence of 2 distinct neoplasms...
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophilsJohann Wojta
Department of Internal Medicine II, University of Vienna, Austria
Blood 100:517-23. 2002....
Recombinant allergens promote expression of CD203c on basophils in sensitized individualsAlexander W Hauswirth
Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
J Allergy Clin Immunol 110:102-9. 2002....
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycinMatthias Mayerhofer
Department of Internal Medicine I, Division of Hematology and Hemostaseology, The University of Vienna, Austria
Blood 100:3767-75. 2002..Together, our data show that BCR/ABL induces VEGF- and HIF-1alpha gene expression through a pathway involving PI3-kinase and mTOR. BCR/ABL-induced VEGF expression may contribute to the pathogenesis and increased angiogenesis in CML...
Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinibStefan Florian
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, , A-1090 Vienna, Austria
Leuk Res 30:1201-5. 2006..Because of the availability of a superior targeted drug (imatinib), it is of importance to screen for FIP1L1/PDGFRalpha in suspected CEL with or without co-existing SM...
Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemiaWolfgang Füreder
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Wahringer Gurtel 18 20, A 1097 Vienna, Austria
Am J Pathol 168:123-30. 2006..05). Taken together, these data show that aplastic anemia is associated with reduced angiogenesis and reduced VEGF expression...
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodesStefan Florian
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Int Arch Allergy Immunol 136:273-80. 2005..Finally, our case further shows that mastocytosis can be an important differential diagnosis to be considered in patients with unexplained anaphylactoid or other mediator-related symptoms...
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosisSophie Ziegler
Division of Haematology and Haemostasis, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
Thromb Res 115:59-64. 2005..In contrast to solid tumors, venous thromboembolism before or at diagnosis of acute leukemia is not associated with poor prognosis...
Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment conceptsChristian Sillaber
Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, AKH Wien, Austria
Wien Klin Wochenschr 115:485-504. 2003..Whether these strategies will lead to curative drug therapy in CML in the future remains at present unknown...
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantationHermine Agis
Department of Internal Medicine I, Medical University of Vienna, Austria
Leuk Lymphoma 45:1453-8. 2004..These data suggest that Imatinib is a useful agent for long term treatment of relapsed CML after allogeneic SCT...
Bone marrow microvessel density and its prognostic significance in AMLWerner Rabitsch
Department of Internal Medicine I, Vienna, Austria
Leuk Lymphoma 45:1369-73. 2004..05). Together, our data suggest that the BM-MVD could be a prognostic parameter concerning survival in patients with AML undergoing allogeneic BMT...
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)Peter Valent
Division of Hematology and Hemostaseology, Department of Internal Medicine I, University of Vienna, Vienna, Austria
Wien Klin Wochenschr 115:515-36. 2003..Recently established scoring systems aimed at predicting survival and evolution of leukemia in MDS may be helpful in this regard...
Mast cell proliferative disorders: current view on variants recognized by the World Health OrganizationPeter Valent
Department of Internal Medicine 1, Division of Hematology and Hemostaseology, University of Vienna, Wahringer Gurtel 18 20, Vienna, Austria
Hematol Oncol Clin North Am 17:1227-41. 2003..In patients with SM-AHNMD, the SM should be treated as if no AHNMD is present, and the AHNMD should be treated as if no SM had been diagnosed...
Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center studyMargit Mitterbauer
Department of Medicine I, Bone Marrow Transplantation Unit, University Hospital of Vienna, Vienna, Austria
Leuk Lymphoma 45:971-7. 2004..In this situation quantitative RT-PCR might help to define individual relapse risk and to improve as well as facilitate clinical decision-making...
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasmsPeter Valent
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
J Allergy Clin Immunol 114:3-11; quiz 12. 2004..The current review provides an overview of mastocytosis and its subvariants and a practical guide that might help to delineate mastocytosis from unrelated systemic disorders...
Assays for measuring in vitro basophil activation induced by recombinant allergensPeter Valent
Division of Hematology and Hemostaseology, Department of Internal Medicine I, The University of Vienna, Vienna, Austria
Methods 32:265-70. 2004..In the current article, the biochemical, functional, and technical background of these basophil tests is discussed...
Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of diseaseMaria-Theresa Krauth
Department of Internal Medicine I, Medical University of Vienna, Austria
Am J Clin Pathol 121:473-81. 2004..Our data show that VEGF is expressed in immature myeloid cells in CML. The extent of VEGF expression depends on the phase of disease and the cell type involved in disease progression...
Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particlesInes Swoboda
Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
J Immunol 172:6490-500. 2004..Our finding that rabbit anti-rPhl p 13 Abs blocked patients' IgE binding to the allergen suggests that rPhl p 13 may be used for immunotherapy of sensitized patients...
Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemiaMatthias Mayerhofer
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
Cancer Res 64:3148-54. 2004..Together, our data identify HO-1 as a novel BCR/ABL-driven survival molecule and potential target in leukemic cells in patients with CML. The pathogenetic and clinical implications of this observation remain to be elucidated...
Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1Stefan Florian
Department of Internal Medicine, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria
J Leukoc Biol 77:984-92. 2005..It is hypothesized that CD172 and CD47 contribute to MC clustering and that the "lack" of SHP-1 in MC may facilitate KIT-dependent signaling in a subgroup of patients...
